ULBI
Ultralife Corporation
6.10$
+2.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -103.3% | – | -46.8% | -35.8% | +10.6% | +76.2% | -96.7% | +652.0% | +51.5% | -47.3% | – | |
| – | -2.1% | +0.2% | +5.0% | -2.2% | +18.6% | +14.9% | +4.6% | +0.1% | -7.9% | +1.1% | +0.2% | – | |
| – | -20.6% | +54.8% | -1.2% | +6.9% | +22.4% | +9.1% | +3.5% | +0.4% | +0.4% | -100.4% | – | – | |
| – | – | – | – | -15.2% | -62.2% | -139.2% | – | -93.2% | -1,145.0% | – | -293.6% | – | |
| – | +88.2% | -63.0% | -3.2% | +65.0% | +2.0% | +47.7% | +22.9% | -9.5% | -11.4% | -12.7% | -41.2% | – | |
| – | +88.2% | -63.0% | -3.2% | +65.0% | – | – | +22.9% | -9.9% | -10.6% | -13.1% | -41.2% | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -101.5% | +291.3% | -74.4% | -0.1% | +200.3% | +48.4% | – | |
| – | -112.4% | – | -6,547.6% | -65.8% | – | -101.5% | +285.9% | -75.4% | +5.5% | +200.3% | +46.7% | – | |
| – | -4.0% | -118.3% | – | – | -4.8% | +2,231.3% | +19.1% | -175.7% | – | -635.3% | – | – | |
| – | – | -131.7% | – | -51.5% | -41.2% | +1.4% | +95.5% | -116.5% | – | +144.8% | -50.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.